Patanjali Foods Buys Non-Food Arm for ₹1,100 Crore

Introduction to the Strategic Acquisition

Patanjali Foods Limited, a major player in the edible oils market, announced a significant strategic move to acquire the non-food business of its promoter entity, Patanjali Ayurved Limited (PAL). The deal, valued at ₹1,100 crore, is designed to accelerate Patanjali Foods' transformation into a diversified Fast-Moving Consumer Goods (FMCG) company. The acquisition, confirmed in a regulatory filing on July 1, 2024, encompasses Patanjali Ayurved's home care, skin care, dental care, and hair care divisions. This transaction is classified as a related-party transaction, which the company states has been negotiated on a fair value and arm's length basis.

Details of the Business Transfer

The board of Patanjali Foods has approved the acquisition of the entire non-food business undertaking through a slump sale arrangement. This includes all associated movable and immovable assets, contracts, licenses, employees, and certain liabilities. The acquisition will bring popular brands such as Dant Kanti (dental care) and Kesh Kanti (hair care) under the Patanjali Foods umbrella. The non-food business operates from a manufacturing facility located at the Patanjali Foods & Herbal Park in Haridwar, Uttarakhand. According to company officials, the acquired business registered a turnover of approximately ₹2,800 crore in the previous fiscal year.

Financial Structure of the Deal

The total consideration for the acquisition is a lump sum of ₹1,100 crore. Patanjali Foods CEO Sanjeev Asthana confirmed that the deal will be funded entirely through the company's internal cash reserves. The payment will be made in five tranches as outlined in the business transfer agreement. The first tranche of ₹220 crore is scheduled to be paid within ten business days of receiving all necessary approvals. The final payment of ₹55 crore will be made upon the successful conveyance of all properties related to the business. This structured payment plan ensures a smooth financial transition without straining the company's liquidity.

The Licensing Agreement

In addition to the acquisition, Patanjali Foods and Patanjali Ayurved have entered into a 20-year licensing agreement. This arrangement permits Patanjali Foods to use the trademarks and associated intellectual property rights owned by PAL, which are crucial for the non-food product portfolio. Under the terms of the agreement, Patanjali Foods will pay a license fee equivalent to 3% of the actual gross sales value of the products. The agreement also stipulates a minimum annual payment of ₹83 crore, which will become effective once the company's infrastructure is fully operational.

A Closer Look at the Related-Party Transaction

This transaction is categorized as a related-party deal because Patanjali Ayurved Limited is one of the promoters of Patanjali Foods, holding a 32.4% stake as of March 31, 2024. Key management personnel hold positions in both entities. Acharya Balkrishna is the Chairman of Patanjali Foods and the Managing Director of PAL, while Ram Bharat serves as the Managing Director of Patanjali Foods and a Director at PAL. To ensure transparency and fairness, the companies have stated that the valuation was conducted by independent valuers and the terms were negotiated at arm's length.

Key Deal Metrics

Path to Completion: Regulatory Approvals

The completion of this acquisition is contingent upon receiving several regulatory and stakeholder approvals. Patanjali Foods must secure clearance from the Competition Commission of India (CCI) to ensure the deal does not violate anti-trust laws. Furthermore, the transaction requires the approval of the company's shareholders and its lenders, including the State Bank of India. The company has initiated the process to obtain these approvals and expects the transaction to be concluded within the current quarter.

Strategic Rationale and Expected Synergies

The primary objective of this acquisition is to consolidate the 'Patanjali' brand's FMCG portfolio under a single listed entity. Patanjali Foods anticipates multiple synergies from this integration. These include enhanced brand equity, opportunities for product innovation, and significant cost optimization in supply chain and distribution. The company also expects improved infrastructure and operational efficiencies, which should positively impact its market share. This move aligns with a series of previous acquisitions, including the biscuit, noodle, and food businesses from Patanjali group entities, all aimed at strengthening its FMCG footprint.

Market Reaction and Broader Context

The market responded positively to the announcement, which was made after trading hours on July 1. Earlier that day, shares of Patanjali Foods had surged by 6.81% to close at ₹1,699.65 on the BSE, reportedly fueled by market speculation about a corporate reorganization. The acquisition places Patanjali Foods in a stronger position to compete with other established FMCG giants in India by expanding its product offerings beyond its core edible oil business.

Conclusion

The acquisition of Patanjali Ayurved's non-food business for ₹1,100 crore is a pivotal step for Patanjali Foods in its journey to become a comprehensive FMCG powerhouse. By integrating a strong portfolio of home and personal care products, the company is poised for significant growth in revenue and market presence. The successful completion of the deal now hinges on securing the necessary regulatory and shareholder approvals in the coming months.